SCHEMBL19546005

SCHEMBL19546005

CNC(COC)C(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19487354 1.00
SCHEMBL8164719 1.00
SCHEMBL17948523 0.87 CA12 (0.37)
SCHEMBL14177531 0.86 KDM4E (0.31)
SCHEMBL13475045 0.84 CA12 (0.39)
SCHEMBL12590416 0.84 MEN1 (0.32)
SCHEMBL23177679 0.84
SCHEMBL13599974 0.84
SCHEMBL14224834 0.83 SMN1; SMN2 (0.39)
SCHEMBL12155238 0.83 SMN1; SMN2 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2017-11-02 US disclosed
US-8263040-B2 contrast agents for necrosis imaging, diagnosis of changes in the lymphatic system, inflammatory diseases, cardiovascular diseases, tumour imaging; radioactive materials use in radiotherapy BAYER SCHERING PHARMA AG (DE) 2012-09-11 US disclosed
US-20080159954-A1 METAL CHELATES HAVING A PERFLUORINATED PEG RADICAL, PROCESSES FOR THEIR PREPARATION, AND THEIR USE BAYER INTELLECTUAL PROPERTY GMBH (DE) 2008-07-03 US disclosed